Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Site × Vemurafenib × 90 days × Clear all

Sponsor

Conditions

Neoplasms 3 Melanoma 3 Lymphoma, Non-Hodgkin 3 Skin Neoplasms 2 Neoplasm Metastasis 2 Multiple Myeloma 2 Leukemia, Hairy Cell 2 Xanthogranuloma, Juvenile 1 Wilms Tumor 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Skin Diseases 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Osteosarcoma 1 Neuroectodermal Tumors, Primitive, Peripheral 1 Neuroblastoma 1 Medulloblastoma 1 Leukemia 1 Histiocytosis, Langerhans-Cell 1 Histiocytic Sarcoma 1 Hepatoblastoma 1 Glioma 1 Ependymoma 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Adenocarcinoma, Follicular 1

Interventions

durvalumab 3 Fulvestrant 3 Cisplatin 3 Carboplatin 3 ribociclib 2 pembrolizumab 2 palbociclib 2 abemaciclib 2 Pemetrexed 2 Letrozole 2 Anastrozole 2 trametinib 1 taletrectinib 1 sotorasib 1 selpercatinib 1 relatlimab 1 pralsetinib 1 exemestane 1 elacestrant 1 darolutamide 1 dabrafenib 1 ceralasertib 1 Watchful Waiting 1 Transurethral Resection of Prostate 1 Sunitinib 1 STX-478 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 RAD1901 1 Pregnancy Tests 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡